AKBA Forecast and Technical Stock Analysis
Buy candidate since 2019-12-06 Gain 8.12% PDF
Akebia Therapeutics gained 0.63% in the last trading day ( Friday, 13th Dec 2019 ), rising from $6.35 to $6.39 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 4.45% from a day low at $6.18 to a day high of $6.45. The price has risen in 6 of the last 10 days and is up by 1.59% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 0.43 million more shares were traded than the day before. In total, 1.25 million shares bought and sold for approximately $7.98 million.
- 30 day high of the AKBA stock price was $6.56 and low was $2.99.
- 90 day high was $6.56 and low was $2.99.
- 52 week high for Akebia Therapeutics - $9.30 and low - $2.99.
Akebia Therapeutics lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $6.50 will firstly indicate a stronger raising rate. Given the current short-term trend, the stock is expected to rise 25.73% during the next 3 months and, with 90% probability hold a price between $4.45 and $8.17 at the end of this period.
Akebia Therapeutics holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $6.19 and $4.55. A break down below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Tuesday December 10, 2019, which indicates further falls until a new bottom pivot has been found.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 73 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
Akebia Therapeutics finds support from accumulated volume at $6.29.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.28 between high and low, or 4.45%. For the last week, the stock has had a daily average volatility of 6.45%.
Our recommended stop-loss: $5.97 (-6.63%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from pivot top found 3 day(s) ago.)
6.45 %Average volatility
Very Low Low Medium High Very High
|AKBA $6.39 ($0.04 0.63%)|
AKBA is up $0.04 today, but where's it headed in 2020?
|Zacks Investment Research is releasing its prediction for AKBA based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the AKBA analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!